irinotecan has been researched along with B16 Melanoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boehm, JC; Caranfa, MJ; Faucette, LF; Gallagher, G; Hecht, SM; Holden, KG; Jakas, DR; Johnson, RK; Kingsbury, WD; McCabe, FL | 1 |
| Cong, Z; Lam, KS; Liao, YH; Ma, SQ; Yang, FF; Zhang, L | 1 |
| Chen, M; Chen, Q; Deng, W; Gong, Y; Jin, Q; Liu, Z; Shen, J; Sun, J; Tan, Y; Wang, C | 1 |
| Fu, Y; Guo, N; Hao, T; Li, J; Liu, J; Liu, Z; Ridwan, KA; Tang, J; Teng, Y; Yang, S; Yang, Y; Yu, P | 1 |
| Hou, B; Hu, X; Lai, Y; Lei, L; Tian, Y; Wang, Y; Xu, J; Xu, Z; Yu, H; Zhang, W | 1 |
| Aljuffali, IA; Fang, JY; Huang, YJ; Sung, CT; Wen, CJ | 1 |
6 other study(ies) available for irinotecan and B16 Melanoma
| Article | Year |
|---|---|
Synthesis of water-soluble (aminoalkyl)camptothecin analogues: inhibition of topoisomerase I and antitumor activity.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cattle; Cell Line; Colonic Neoplasms; DNA, Superhelical; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Humans; Indicators and Reagents; Leukemia L1210; Lung Neoplasms; Melanoma, Experimental; Mice; Molecular Structure; Plasmids; Structure-Activity Relationship; Thymus Gland; Topoisomerase I Inhibitors; Transplantation, Heterologous | 1991 |
Size-Transformable Hyaluronan Stacked Self-Assembling Peptide Nanoparticles for Improved Transcellular Tumor Penetration and Photo-Chemo Combination Therapy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Combined Modality Therapy; Disease Models, Animal; Dopamine; Female; Folic Acid; Hyaluronic Acid; Indocyanine Green; Injections, Intravenous; Irinotecan; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nanoparticles; Optical Imaging; Particle Size; Peptides; Rats; Rats, Wistar; Surface Properties | 2020 |
Injectable Reactive Oxygen Species-Responsive SN38 Prodrug Scaffold with Checkpoint Inhibitors for Combined Chemoimmunotherapy.
Topics: Animals; Antineoplastic Agents; Boronic Acids; Cell Death; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Female; Immunotherapy; Irinotecan; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Molecular Structure; Particle Size; Polyvinyl Alcohol; Prodrugs; Programmed Cell Death 1 Receptor; Reactive Oxygen Species; Surface Properties; T-Lymphocytes | 2020 |
Tumor vasculature-targeting PEGylated peptide-drug conjugate prodrug nanoparticles improve chemotherapy and prevent tumor metastasis.
Topics: Animals; Cell Adhesion; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Humans; Irinotecan; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Nude; Nanoparticles; Peptides; Polyethylene Glycols; Prodrugs; Survival Rate; Transplantation, Heterologous | 2021 |
Bioinspired Multivalent Peptide Nanotubes for Sialic Acid Targeting and Imaging-Guided Treatment of Metastatic Melanoma.
Topics: Animals; Boronic Acids; Humans; Irinotecan; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Nude; N-Acetylneuraminic Acid; Nanotubes, Peptide; Topoisomerase I Inhibitors | 2019 |
Nanocomposite liposomes containing quantum dots and anticancer drugs for bioimaging and therapeutic delivery: a comparison of cationic, PEGylated and deformable liposomes.
Topics: Animals; Antineoplastic Agents; Calorimetry, Differential Scanning; Camptothecin; Cations; Cell Survival; Diagnostic Imaging; Drug Delivery Systems; Female; Irinotecan; Liposomes; Melanoma, Experimental; Mice; Mice, Nude; Nanocomposites; Particle Size; Phosphatidylcholines; Polyethylene Glycols; Quantum Dots; Spectrometry, Fluorescence; Static Electricity; Wound Healing | 2013 |